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Down syndrome (trisomy 21, or DS) is 
the most common live-born aneuploidy in 
humans, occurring in approximately 1 in 700 
live births (1). The inheritance of three copies 
of human chromosome 21 (Hsa21) results in a 
wide range of phenotypes including cognitive 
impairment, cardiac defects, and cranio-
facial dysmorphology (2,3). Conserved gene 
content and order occurs between Hsa21 
and murine chromosomes Mmu16, Mmu17, 
and Mmu10 (4,5). To better understand the 
gene-phenotype relationship in DS, partial 
or segmental trisomies have been created in 
mice with triplicated portions of the murine 
genome that correspond to Hsa21. Numerous 
phenotypes associated with DS have been 
documented in mouse models (recently 
reviewed in References 6 and 7).
The most widely used and well-studied 
mouse model of trisomy and DS pheno-
types is the Ts(1716)65Dn (written hereafter 
as Ts65Dn). To create this mouse, DBA/2J 
male mice with irradiated testes were bred 
to C57BL/6J female mice, and offspring 
carrying reciprocal translocations for Mmu16 
were bred to B6C3F1 mice (8). The resultant 
T(16C3–4;17A2)65Dn heterozygote mice 
produced offspring with the small marker 
chromosome consisting of the telomeric 
13.5 Mb of Mmu16, attached to a Mmu17 
centromere with a small amount of euchro-
matic material (9,10). Ts65Dn mice are 
trisomic for orthologs of approximately half 
of the genes on Hsa21 and show DS-related 
phenotypes including reduced birthweight, 
perinatal lethality, craniofacial abnormal-
ities, cognitive and behavioral impairments, 
cardiovascular malformations, and neuro-
logical structural deficiencies (11–14). Inves-
tigations using this mouse model have been 
used to predict human phenotypes as well as 
to examine potential therapies to correct traits 
associated with DS (6,15,16).
Ts65Dn mice serve as an excellent genetic 
and phenotypic model for DS; however, they 
are difficult to produce and genotype. Gener-
ating Ts65Dn mice is complicated given that 
males are subfertile, females are poor mothers, 
and offspring are limited due to perinatal loss 
(10,12,14). With all of these factors, trisomic 
pups account for ~40% of the litter on the 
day of birth. Physical differences have been 
observed between offspring containing the 
segmental trisomic and euploid littermates, but 
these phenotypes are highly variable and not 
reliable for positive identification of Ts65Dn 
mice (9,14). Ts65Dn mice were first genotyped 
using karyotypes from cultured lymphocytes 
or meiotic cells, a procedure taking 2–3 days 
and only done in adult mice (8). Fluorescence 
in situ hybridization (FISH) of nucleated 
blood cells at interphase has been used as the 
standard for identifying Ts65Dn mice, but this 
method is also labor-intensive and generally 
requires 2–3 days (17). Recently, a number 
of quantitative PCR methods have also been 
used to quantify trisomic gene copy number in 
Ts65Dn mice (18–21). While these processes 
may be relatively fast, results can be difficult 
to interpret, reagents are expensive, and few 
laboratories have the necessary equipment—
thus requiring the service of a core facility 
(20). Erroneous inclusion of euploid mice as 
trisomic in assessment of a subtle phenotype 
can significantly reduce the accuracy of subse-
quent phenotyping procedures.
To prescreen Ts65Dn mice and reduce 
the time and cost of subsequent FISH identi-
fication of the trisomic segment, we have 
developed a simple methodology requiring 
the restriction digest of a PCR product 
amplified from the small translocation 
marker chromosome (1716). Our method-
ology utilizes a single nucleotide polymor-
phism (SNP) within the Zdhhc14 gene on 
Mmu17 near the breakpoint of the translo-
cation chromosome. The SNP is polymorphic 
between the DBA/2J reciprocal translocation 
founder strain and the C57BL/6J and C3H/
HeJ strains that contribute to the majority of 
the background of Ts65Dn mice. Crosses 
between Ts65Dn and B6C3F1 mice result 
in offspring with two normal Mmu17 with 
C57BL/6J or C3H/HeJ alleles. In most, but 
not all cases, trisomic offspring will have the 
DBA/2J Zdhhc14 allele at the Mmu17 centro-
meric end of the chimeric chromosome due 
to limited crossovers during meiosis within 
the region delimited by the SNP and the 
Mmu1716 breakpoint. PCR amplification of 
the area surrounding the SNP allows for the 
selective digest of C57BL/6J or C3H/HeJ 
product by SacI, which produces bands of 175 
bp and 71 bp in length. Ts65Dn mice with 
the DBA/2J allele at the SNP will display a 
full-length PCR product (246 bp) in addition 
to the digested products from the additional 
copies of Mmu17 with C57BL/6J or C3H/
HeJ alleles (the 71-bp band can be difficult to 
visualize on an agarose gel) (Figure 1) .
In total, 1174 offspring from Ts65Dn × 
B6C3F1 matings were genotyped using this 
PCR and restriction enzyme methodology. 
Of those, 716 were sexed and were comprised 
of 50.3% males and 49.7% females. At 
weaning, 32.7% of 892 offspring carried 
the distinguishing DBA/2J Zdhhc14 allele 
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Figure 1. PCR/restriction digest typing for the 
T65Dn marker chromosome using the Zdhhc14 
polymorphism. (A) PCR/restriction digest typing 
for the T65Dn marker chromosome in offspring 
from Ts65Dn × B6C3F1 matings. Euploidy or 
trisomy of offspring was verified by FISH. Lane 
1: molecular weight markers. Lane 2: before 
digestion, a 246-bp PCR fragment is produced 
from all offspring of a Ts65Dn × B6C3F1 mat-
ing and derives from the B6, C3H, or DBA Zd-
hhc14 alleles. (DNA is from a Ts65Dn trisomic 
pup.) Lane 3: in euploid offspring, both the B6 
and C3H alleles result in SacI restriction digest 
products of 175-bp and 71-bp. Lane 4: Ts65Dn 
offspring have one copy of the 246-bp band from 
the T65Dn marker chromosome, plus the 175- 
and 71-bp bands from the two normal parental 
chromosomes. (B) The site of Zdhhc14 polymor-
phism relative to primers. Location of SNP and 
SacI restriction endonuclease site (blue) between 





on the translocation chromosome. Both 
positive and negative PCR results from 603 
pups were confirmed using FISH with an 
overall 3.1% false positive rate and a 5.2% 
false negative rate (Table 1).
Our methodolgy is inexpensive, identifies 
trisomic mice with more than 90% concor-
dance to FISH genotyping, can be done in 
most laboratories, and takes ~6 h to complete 
(instrument run times and incubations take 
the majority of this time). We have utilized 
this methodology to reduce the subsequent 
FISH analysis by 60–70%. For example, in 
a subset of 338 female mice from a breeding 
colony that were genotyped using the 
described PCR protocol, 101 were confirmed 
by FISH results. Additional negative mice 
were selected and FISH-genotyped to serve as 
controls. This corresponds to a concomitant 
reduction in time and cost of the subsequent 
genotyping, though the exact cost may vary 
depending on the laboratory. The method-
ology can only prescreen Ts65Dn offspring 
due to the small frequency of recombination 
events between the small centromeric end of 
Mmu17 on the marker chromosomes (origi-
nally derived from DBA/2J) and corre-
sponding regions on the two full-length copies 
of Mmu17 (largely derived from the B6C3F1 
males after generations of crossing onto this 
background). We have utilized this method-
ology in our colonies as a cost effective and 
efficient method to prescreen Ts65Dn mice 
for experimental procedures and continued 
mating, with subsequent FISH identification 
of the small marker chromosome.
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